Testimonial Writing a H2020 proposal is an enormous task and requires not only excellent science but also substantial experience in proposal writing. accelopment also provides useful assistance in terms of project management and communication.
Dr. Ekaterine Berishvili
VANGUARD Project Coordinator
University of Geneva, Switzerland

<< Projects

VANGUARD

New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes

Forty million individuals worldwide suffer from type 1 diabetes. This disease is managed by insulin therapy in a vast majority of patients because of the limited accessibility of beta cell replacement therapies (pancreas or islet of Langerhans transplantation). There is an urgent need for the development of a beta cell replacement therapy that will be available to larger numbers of type 1 diabetic patients.

The VANGUARD project aims to deliver an Advanced Therapeutic Medicinal Product (ATMP) of high translational potential, with properties of increased functionality and implantability and protection from immune destruction. We will construct a bioartificial pancreas by assembling insulin-producing organoids, composed of islet cells, human amniotic epithelial cells (hAEC) and blood outgrowth endothelial cells (BOECs), into an amniotic membrane-derived hydrogel. Components of the amniotic membrane will provide extracellular matrix and mechanical protection and confer their well-defined anti-inflammatory and immunomodulatory properties to the constructs. hAECs will be genome-edited to overexpress and locally release immunomodulatory molecules (HLA-G, HLA-E, CD47 and PD-L1) and endothelial cells will enhance graft revascularization. Functionality, biocompatibility, potency and safety of the bioartificial pancreas will be assessed in vitro and in vivo by implantation in mice reconstituted with a human immune system as pre-clinical model.

The consortium consists of 6 academic institutions with leading scientists in their field, 2 SMEs and 1 NGO with expertise in ethical and social aspects of transplantation.

The ATMP delivered upon completion of the project will provide a model for rapid development of a bioartificial pancreas, utilizing “infinite” sources of insulin-producing cells (stem cell-derived, xenogeneic), and available to all type 1 diabetic patients before they develop the devastating chronic complications of the disease.

Read more about VANGUARD on Horizon, the official EU magazine for EU-funded projects: https://horizon-magazine.eu/article/lab-grown-and-do-it-yourself-two-emerging-routes-artificial-pancreas.html

This project contributes to the UN Sustainable Development Goal (SDG) 3.

Coordinator:
Université de Genève, CH

Partners:

Funded Project




AreaManufacturing
ProgrammeCTI
Duration01.09.2012 - 12.08.2014
Budget0.58 million euro
More


Communication, Dissemination, Exploitation



Your EU project and your research results are expected to have an impact on current societal challenges, Europe`s innovation capacity and competitiveness. Communication, dissemination and exploitation activities are essential in achieving these objectives. Many of these activities require specific skills such as graphic design, communication strategy development and science communication writing. We have this skill-set.

More

Team



By helping researchers and companies focus on their innovations, we contribute to addressing a wide range of global challenges. This alone makes our work rewarding and exciting.

Dr. Marco Cavallaro
Research & Innovation Project Manager